Full Text (PDF)
Review Article

Ketamine Therapy in Psychiatry: A Comprehensive Review

Asif Khan , Asif Khan1 , Satyaveer2 , Shrikant K Nair3 , Deepali Gaikwad Joseph4

Author Information

Licence:




Journal of Psychiatric Nursing 14(1):p 31-36, Jan- April 2025. | DOI: 10.21088/jpn.2277.9035.14125.5

How Cite This Article:

Asif Khan, Satyaveer, Shrikant K Nair, Deeksha Srivastava et. al, Ketamine Therapy in Psychiatry: A Comprehensive Review. J Psychiatr Nurs. 2025; 14(1): 31–36.
 


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Ketamine, traditionally known as an anesthetic agent, has garnered attention for its rapid acting antidepressant properties, particularly in patients with treatment resistant depression (TRD). The compound’s unique pharmacological profile primarily as an NMDA receptor antagonist has enabled its repositioning in psychiatric settings, where conventional antidepressants often fall short. This review delves into the evolving role of ketamine in psychiatry, examining its mechanisms of action, therapeutic applications, clinical efficacy, safety concerns, and emerging trends in the field. While ketamine therapy offers promise, its use raises ethical, regulatory, and long-term safety considerations that require continued research and careful implementation.
 


References

No records found.


Data Sharing Statement

There are no additional data available

Funding

This research received no funding

Author Contributions

All authors contributed significantly to the work and approve its publication

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval

Acknowledgements

Information Not Provided

Conflicts of Interest

No conflicts of interest in this work


About this article


Cite this article

Asif Khan, Satyaveer, Shrikant K Nair, Deeksha Srivastava et. al, Ketamine Therapy in Psychiatry: A Comprehensive Review. J Psychiatr Nurs. 2025; 14(1): 31–36.
 


Licence:




Received Accepted Published
N/A N/A N/A

DOI: 10.21088/jpn.2277.9035.14125.5

Keywords

Ketamine • Psychiatry • Depression • NMDA receptor • Antidepressant Treatment-resistant depression • Mental health • Suicidality • Glutamatergic system • Neuroplasticity

Article Level Metrics

Last Updated

Sunday 01 March 2026, 05:37:28 (IST)


154

Accesses

3
68
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share